Tripoli: The Medical Supply Authority has announced the receipt of a new shipment of medication for muscle atrophy, provided by the Swiss pharmaceutical giant Roche. This shipment is set to meet the needs of patients for an entire year.
According to Libyan News Agency, the Medical Supply Authority emphasized that the supply process adhered to approved technical and logistical standards. It was further assured that the medications will undergo standard regulatory procedures and laboratory tests to confirm their safety and quality before they are distributed to patients.
The arrival of this shipment is part of the Medical Supply Authority’s continuous efforts to secure essential medicines and specialized treatments. The Authority is committed to enhancing the efficiency of the drug supply system to maintain the sustainability of health services across the country.